The Stock of Gilead Which Makes Remdesivir Is Back Down to Its Pre-Pandemic Price
313
Could the diving stock price of Gilead, the maker of Remdesivir, a major competitor of HCQ be related to the evolving evidence of the effectiveness the availability of HCQ?